ArticleACS omega2026
On-Site Electrochemical Detection of Sulfentrazone Using a Fully 3D-Printed Portable Sensing Platform.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The widespread use of pesticides in agricultural activities has increased concerns regarding environmental contamination and occupational exposure, particularly through dermal contact. In this work, we report a portable and low-cost electrochemical sensing platform for on-site monitoring of sulfentrazone (SFT), a herbicide extensively used in eucalyptus cultivation. The proposed device consists of a fully 3D-printed miniaturized electrochemical system fabricated by multi-material printing using conductive and non-conductive filaments, enabling accessible and decentralized analysis. SFT detection was performed by square-wave voltammetry (SWV), exhibiting a single irreversible oxidation peak at +0.86 V (pH 6.5). Under optimized conditions, the platform showed a linear response from 1.1 to 101.1 μmol L
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.